6-arylmethylprazolo[3,4-d]pyrimidines

US7615558B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Martin Hendrix · Tarrytown, US
• Lars Bärfacker · Oberhausen, DE
• Christina Erb · Wiesbaden, DE
• Frank-Thorsten Hafner · Wuppertal, DE
• Heike Heckroth · Wuppertal, DE
• Dagmar Karthaus · Solingen, DE
• Adrian Tersteegen · Wuppertal, DE
• Franz-Josef van der Staay · Dronten, NL
• Marja Van Kampen · Neu-Isenburg, DE

Key dates

• Filing date: Apr 27, 2004
• Grant date: Nov 10, 2009
• Expiry date: Apr 27, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Described are 6-arylmethylpyrazolo[3,4-d]pyrimidines of the following formula:processes for their preparation and their use for producing medicaments for improving perception, concentration, learning and/or memory.